Monday, May 7, 2012

Tarceva Patent ruled in favor of OSI / Astellas / Genentec

In the Tarceva patent infringment suit against, Mylan, The US district court has annoucned a ruling in favor of Astellas/OSI pharmaceuticals/Genentech. Mylan had filed a Para-IV seeking permission to market a generic version of Tarceva, before expiry of Tarceva patents ( 5747498 and 6900221)